Price Chart

Profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
URL https://www.bio-techne.com
Investor Relations URL https://investors.bio-techne.com/
HQ State/Province Minnesota
Sector Healthcare
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Feb. 09, 2024

Profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
URL https://www.bio-techne.com
Investor Relations URL https://investors.bio-techne.com/
HQ State/Province Minnesota
Sector Healthcare
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Feb. 09, 2024